{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:58:03Z","timestamp":1791284283797,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,3,16]],"date-time":"2008-03-16T00:00:00Z","timestamp":1205625600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1038\/nm1737","type":"journal-article","created":{"date-parts":[[2008,3,16]],"date-time":"2008-03-16T17:09:26Z","timestamp":1205687366000},"page":"407-412","source":"Crossref","is-referenced-by-count":230,"title":["Identification of oxadiazoles as new drug leads for the control of schistosomiasis"],"prefix":"10.1038","volume":"14","author":[{"given":"Ahmed A","family":"Sayed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Simeonov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig J","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Inglese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,3,16]]},"reference":[{"key":"BFnm1737_CR1","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/NEJMra064142","volume":"357","author":"PJ Hotez","year":"2007","unstructured":"Hotez, P.J. et al. Control of neglected tropical diseases. N. Engl. J. Med. 357, 1018\u20131027 (2007).","journal-title":"N. Engl. J. Med."},{"key":"BFnm1737_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0001-706X(03)00029-9","volume":"86","author":"MJ van der Werf","year":"2003","unstructured":"van der Werf, M.J. et al. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop. 86, 125\u2013139 (2003).","journal-title":"Acta Trop."},{"key":"BFnm1737_CR3","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/S0140-6736(05)66457-4","volume":"365","author":"CH King","year":"2005","unstructured":"King, C.H., Dickman, K. & Tisch, D.J. Reassessment of the cost of chronic helminthic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 365, 1561\u20131569 (2005).","journal-title":"Lancet"},{"key":"BFnm1737_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S1473-3099(06)70521-7","volume":"6","author":"P Steinmann","year":"2006","unstructured":"Steinmann, P., Keiser, J., Bos, R., Tanner, M. & Utzinger, J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect. Dis. 6, 411\u2013425 (2006).","journal-title":"Lancet Infect. Dis."},{"key":"BFnm1737_CR5","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/01.qco.0000247591.13671.6a","volume":"19","author":"A Fenwick","year":"2006","unstructured":"Fenwick, A. & Webster, J.P. Schistosomiasis: challenges for control, treatment and drug resistance. Curr. Opin. Infect. Dis. 19, 577\u2013582 (2006).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"BFnm1737_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/clinids\/20.2.309","volume":"20","author":"BL Herwaldt","year":"1995","unstructured":"Herwaldt, B.L., Tao, L.F., van Pelt, W., Tsang, V.C. & Bruce, J.I. Persistence of Schistosoma haematobium infection despite multiple courses of therapy with praziquantel. Clin. Infect. Dis. 20, 309\u2013315 (1995).","journal-title":"Clin. Infect. Dis."},{"key":"BFnm1737_CR7","doi-asserted-by":"crossref","first-page":"458","DOI":"10.5694\/j.1326-5377.1996.tb138598.x","volume":"165","author":"SQ Murray-Smith","year":"1996","unstructured":"Murray-Smith, S.Q., Scott, B.J., Barton, D.P. & Weinstein, P. A case of refractory schistosomiasis. Med. J. Aust. 165, 458 (1996).","journal-title":"Med. J. Aust."},{"key":"BFnm1737_CR8","doi-asserted-by":"publisher","first-page":"932","DOI":"10.4269\/ajtmh.1999.60.932","volume":"60","author":"M Ismail","year":"1999","unstructured":"Ismail, M. et al. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. Am. J. Trop. Med. Hyg. 60, 932\u2013935 (1999).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"BFnm1737_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.4269\/ajtmh.1994.51.83","volume":"51","author":"PG Fallon","year":"1994","unstructured":"Fallon, P.G. & Doenhoff, M.J. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. Am. J. Trop. Med. Hyg. 51, 83\u201388 (1994).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"BFnm1737_CR10","first-page":"105","volume":"8","author":"J Utzinger","year":"2007","unstructured":"Utzinger, J., Xiao, S.H., Tanner, M. & Keiser, J. Artemisinins for schistosomiasis and beyond. Curr. Opin. Investig. Drugs 8, 105\u2013116 (2007).","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"BFnm1737_CR11","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/0169-4758(93)90138-6","volume":"9","author":"D Cioli","year":"1993","unstructured":"Cioli, D., Pica-Mattoccia, L. & Archer, S. Drug resistance in schistosomes. Parasitol. Today 9, 162\u2013166 (1993).","journal-title":"Parasitol. Today"},{"key":"BFnm1737_CR12","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1371\/journal.pmed.0040014","volume":"4","author":"MH Abdulla","year":"2007","unstructured":"Abdulla, M.H., Lim, K.C., Sajid, M., McKerrow, J.H. & Caffrey, C.R. Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor. PLoS Med. 4, e14 (2007).","journal-title":"PLoS Med."},{"key":"BFnm1737_CR13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.trstmh.2006.06.006","volume":"101","author":"LS Moreira","year":"2007","unstructured":"Moreira, L.S., Pil\u00f3-Veloso, D., de Mello, R.T., Coelho, P.M. & Nelson, D.L. A study of the activity of 2-(alkylamino)-1-phenyl-1-ethanethiosulfuric acids against infection by Schistosoma mansoni in a murine model. Trans. R. Soc. Trop. Med. Hyg. 101, 385\u2013390 (2007).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"BFnm1737_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0753-3322(03)00043-X","volume":"57","author":"DM Townsend","year":"2003","unstructured":"Townsend, D.M., Tew, K.D. & Tapiero, H. The importance of glutathione in human disease. Biomed. Pharmacother. 57, 145\u2013155 (2003).","journal-title":"Biomed. Pharmacother."},{"key":"BFnm1737_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1089\/ars.2007.9.25","volume":"9","author":"CH Lillig","year":"2007","unstructured":"Lillig, C.H. & Holmgren, A. Thioredoxin and related molecules-from biology to health and disease. Antioxid. Redox Signal. 9, 25\u201347 (2007).","journal-title":"Antioxid. Redox Signal."},{"key":"BFnm1737_CR16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0166-6851(02)00031-2","volume":"121","author":"HM Alger","year":"2002","unstructured":"Alger, H.M. & Williams, D.L. The disulfide redox system of Schistosoma mansoni and the importance of a multifunctional enzyme, thioredoxin glutathione reductase. Mol. Biochem. Parasitol. 121, 129\u2013139 (2002).","journal-title":"Mol. Biochem. Parasitol."},{"key":"BFnm1737_CR17","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1371\/journal.pmed.0040206","volume":"4","author":"AN Kuntz","year":"2007","unstructured":"Kuntz, A.N. et al. Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target. PLoS Med. 4, e206 (2007).","journal-title":"PLoS Med."},{"key":"BFnm1737_CR18","doi-asserted-by":"publisher","first-page":"11473","DOI":"10.1073\/pnas.0604348103","volume":"103","author":"J Inglese","year":"2006","unstructured":"Inglese, J. et al. Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries. Proc. Natl. Acad. Sci. USA 103, 11473\u201311478 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1737_CR19","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1371\/journal.pntd.0000127","volume":"2","author":"A Simeonov","year":"2008","unstructured":"Simeonov, A. et al. Quantitative high-throughput screen identifies inhibitors of the Schistosoma mansoni redox cascade. PLoS Negl. Trop. Dis 2, e127 (2008).","journal-title":"PLoS Negl. Trop. Dis"},{"issue":"Suppl. 1","key":"BFnm1737_CR20","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1517\/17460441.2.S1.S53","volume":"2","author":"B Ramirez","year":"2007","unstructured":"Ramirez, B. et al. Schistosomes: challenges in compound screening. Expert Opin. Drug Discov. 2 (Suppl. 1), S53\u2013S61 (2007).","journal-title":"Expert Opin. Drug Discov."},{"key":"BFnm1737_CR21","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/0006-2952(92)90379-W","volume":"44","author":"M Feelisch","year":"1992","unstructured":"Feelisch, M., Sch\u00f6nafinger, K. & Noack, E. Thiol-mediated generation of nitric oxide accounts for the vasodilator action of furoxans. Biochem. Pharmacol. 44, 1149\u20131157 (1992).","journal-title":"Biochem. Pharmacol."},{"key":"BFnm1737_CR22","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1021\/bi00054a013","volume":"32","author":"T Akaike","year":"1993","unstructured":"Akaike, T. et al. Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor\/NO through a radical reaction. Biochemistry 32, 827\u2013832 (1993).","journal-title":"Biochemistry"},{"key":"BFnm1737_CR23","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/S0140-6736(02)09096-7","volume":"359","author":"P Trouiller","year":"2002","unstructured":"Trouiller, P. et al. Drug development for neglected diseases: a deficient market and a public-health policy failure. Lancet 359, 2188\u20132194 (2002).","journal-title":"Lancet"},{"key":"BFnm1737_CR24","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1126\/science.1105511","volume":"306","author":"CP Austin","year":"2004","unstructured":"Austin, C.P., Brady, L.S., Insel, T.R. & Collins, F.S. NIH Molecular Libraries Initiative. Science 306, 1138\u20131139 (2004).","journal-title":"Science"},{"key":"BFnm1737_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2174\/1389557053402864","volume":"5","author":"H Cerecetto","year":"2005","unstructured":"Cerecetto, H. & Porcal, W. Pharmacological properties of furoxans and benzofuroxans: recent developments. Mini Rev. Med. Chem. 5, 57\u201371 (2005).","journal-title":"Mini Rev. Med. Chem."},{"key":"BFnm1737_CR26","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.4049\/jimmunol.143.12.4208","volume":"143","author":"SL James","year":"1989","unstructured":"James, S.L. & Glaven, J. Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates. J. Immunol. 143, 4208\u20134212 (1989).","journal-title":"J. Immunol."},{"key":"BFnm1737_CR27","doi-asserted-by":"publisher","first-page":"4412","DOI":"10.1021\/jm00051a020","volume":"37","author":"C Medana","year":"1994","unstructured":"Medana, C. et al. Furoxans as nitric oxide donors. 4-Phenyl-3-furoxancarbonitrile: thiol-mediated nitric oxide release and biological evaluation. J. Med. Chem. 37, 4412\u20134416 (1994).","journal-title":"J. Med. Chem."},{"key":"BFnm1737_CR28","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/S0891-5849(01)00724-9","volume":"31","author":"J Nordberg","year":"2001","unstructured":"Nordberg, J. & Arner, E.S. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 31, 1287\u20131312 (2001).","journal-title":"Free Radic. Biol. Med."},{"key":"BFnm1737_CR29","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nrd2144","volume":"5","author":"S Nwaka","year":"2006","unstructured":"Nwaka, S. & Hudson, A. Innovative lead discovery strategies for tropical diseases. Nat. Rev. Drug Discov. 5, 941\u2013955 (2006).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnm1737_CR30","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/0014-4894(86)90184-0","volume":"61","author":"AA Sabah","year":"1986","unstructured":"Sabah, A.A., Fletcher, C., Webbe, G. & Doenhoff, M.J. Schistosoma mansoni: chemotherapy of infections of different ages. Exp. Parasitol. 61, 294\u2013303 (1986).","journal-title":"Exp. Parasitol."},{"key":"BFnm1737_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S1383-5769(00)00028-3","volume":"49","author":"X Shuhua","year":"2000","unstructured":"Shuhua, X., Chollet, J., Weiss, N.A., Bergquist, R.N. & Tanner, M. Preventive effect of artemether in experimental animals infected with Schistosoma mansoni. Parasitol. Int. 49, 19\u201324 (2000).","journal-title":"Parasitol. Int."},{"key":"BFnm1737_CR32","first-page":"19.1.1","volume-title":"Current Protocols in Immunology","author":"F Lewis","year":"1998","unstructured":"Lewis, F. Schistosomiasis. in Current Protocols in Immunology (eds. Coligan, J.E., Kruisbeek, A.M., Margulies, D.H., Shevach, E.M. & Strober, W.) 19.1.1\u201319.1.28 (John Wiley & Sons, New York, 1998)."},{"key":"BFnm1737_CR33","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/B978-0-12-091302-2.50010-4","volume-title":"Methods of Enzymatic Analysis","author":"HU Bergmeyer","year":"1974","unstructured":"Bergmeyer, H.U. & Bernt, E. Lactate dehydrogenase. in Methods of Enzymatic Analysis Vol. 2 (ed. Bergmeyer, H.U.) 574\u2013548 (Academic Press, New York, 1974)."},{"key":"BFnm1737_CR34","first-page":"54","volume":"61","author":"G Aguirre","year":"2006","unstructured":"Aguirre, G. et al. Furoxan derivatives as cytotoxic agents: preliminary in vivo antitumoral activity studies. Pharmazie 61, 54\u201359 (2006).","journal-title":"Pharmazie"},{"key":"BFnm1737_CR35","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/jnci\/82.13.1107","volume":"82","author":"P Skehan","year":"1990","unstructured":"Skehan, P. et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 82, 107\u2013112 (1990).","journal-title":"J. Natl. Cancer Inst."},{"key":"BFnm1737_CR36","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1006\/meth.1995.1007","volume":"7","author":"RW Nims","year":"1995","unstructured":"Nims, R.W. et al. Colorimetric methods for the determination of nitric oxide concentration in neutral aqueous solutions. Methods 7, 48\u201354 (1995).","journal-title":"Methods"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm1737.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1737","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1737.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:31:10Z","timestamp":1684434670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,16]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["BFnm1737"],"URL":"https:\/\/doi.org\/10.1038\/nm1737","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1116498.572524","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,16]]}}}